XML 75 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated (Deficit)
Accumulated (Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance at Dec. 31, 2018 $ 428,340 $ (502) $ 573 $ 1,006,822 $ 0 $ (579,055) $ (502)
Beginning balance (in shares) at Dec. 31, 2018     57,331,622   0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Purchase of treasury stock (in shares)         (23,952,756)    
Purchase of treasury stock (see Note 9) (437,962)       $ (437,962)    
Exercise of stock options (in shares)     111,660        
Exercise of stock options 1,880   $ 1 1,879      
Net (loss) income 37,557         37,557  
Ending balance at Sep. 30, 2019 29,313   $ 574 1,008,701 $ (437,962) (542,000)  
Ending balance (in shares) at Sep. 30, 2019     57,443,282   (23,952,756)    
Beginning balance at Jun. 30, 2019 27,725   $ 573 1,006,822 $ (437,942) (541,728)  
Beginning balance (in shares) at Jun. 30, 2019     57,331,622   (23,952,756)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     111,660        
Exercise of stock options 1,880   $ 1 1,879      
Other (20)       $ (20)    
Net (loss) income (272)         (272)  
Ending balance at Sep. 30, 2019 29,313   $ 574 1,008,701 $ (437,962) (542,000)  
Ending balance (in shares) at Sep. 30, 2019     57,443,282   (23,952,756)    
Beginning balance at Dec. 31, 2019 27,260   $ 574 1,008,701 $ (437,962) (544,053)  
Beginning balance (in shares) at Dec. 31, 2019     57,443,282   (23,952,756)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Purchase of treasury stock (in shares)         (2,682,042)    
Purchase of treasury stock (see Note 9) (30,626)       $ (30,626)    
Exercise of stock options (in shares)     26,109        
Exercise of stock options 356   $ 1 355      
Private placement (in shares)         68,857    
Private placement (see Note 9) 444     (813) $ 1,257    
Net (loss) income 39,421         39,421  
Ending balance at Sep. 30, 2020 36,855   $ 575 1,008,243 $ (467,331) (504,632)  
Ending balance (in shares) at Sep. 30, 2020     57,469,391   (26,565,941)    
Beginning balance at Jun. 30, 2020 36,500   $ 574 1,009,001 $ (468,588) (504,487)  
Beginning balance (in shares) at Jun. 30, 2020     57,463,943   (26,634,798)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     5,448        
Exercise of stock options 56   $ 1 55      
Private placement (in shares)         68,857    
Private placement (see Note 9) 444     (813) $ 1,257    
Net (loss) income (145)         (145)  
Ending balance at Sep. 30, 2020 $ 36,855   $ 575 $ 1,008,243 $ (467,331) $ (504,632)  
Ending balance (in shares) at Sep. 30, 2020     57,469,391   (26,565,941)